TAG:
laboratory executive
Physician Management Companies Exploding, Will Transform Healthcare
By Robert Michel | From the Volume IV No. 10 – July 14, 1997 Issue
CEO SUMMARY: Consolidation and integration of healthcare services will be the dominant trend during the next five years. It happened to commercial laboratories from 1985-95. Widespread hospital consolidation began around 1990 and continues today. Now consolidation is coming to physicians….
Dismal Hospital Finances Behind Lab Joint Venture
By Robert Michel | From the Volume IV No. 10 – July 14, 1997 Issue
CEO SUMMARY: 1995 marked a pace-setting agreement between Columbia and LabCorp. LabCorp would consolidate and manage the laboratories at three Columbia Hospitals. All participants agree that the project has met expectations. But Columbia has yet to clone this model elsewhere. Here’s why…
Future Laboratory Model Found In Oklahoma City
By Robert Michel | From the Volume IV No. 9 – June 23, 1997 Issue
CEO SUMMARY: Even as commercial laboratories struggle to maintain financial solvency, Urocor displays phenomenal growth in specimen volume, market share and revenue during the last five years. It is no accident that this laboratory is succeeding. Urocor’s executives use sophisticated ma…
Management Philosophy Drives UroCor’s Success
By Robert Michel | From the Volume IV No. 9 – June 23, 1997 Issue
CEO SUMMARY: In the year 1997, UroCor shows a financial strength and growth potential unlike most commercial laboratories. UroCor’s current success is a direct result of how UroCor’s management did things differently during the years from 1991 to the present. Much of UroCor’s succes…
Pap Smear Technologies Battle For Market Share
By Robert Michel | From the Volume IV No. 9 – June 23, 1997 Issue
CEO SUMMARY: Cytyc, NeoPath and Neuromedical each tapped the public capital markets during the past 18 months. Now investors expect to see earnings growth and dividends as soon as possible. Clinical laboratories should expect intensified sales and marketing efforts from these three compan…
National Labs Cut Costs Using Radical Strategies
By Robert Michel | From the Volume IV No. 8 – June 2, 1997 Issue
CEO SUMMARY: All three national laboratories are dumping unprofitable accounts and unprofitable lines of testing. It ends the era when commercial labs “gave away” testing to any client willing to open an account. The three national laboratories are enacting stiffer requirements for ne…
National Lab Strategies Will Impact Competitors
By Robert Michel | From the Volume IV No. 8 – June 2, 1997 Issue
CEO SUMMARY: Not since the era of commercial lab consolidation ended has such a significant trend emerged. As the three national labs eliminate service to unprofitable accounts, profound changes will occur to the market for laboratory and pathology services. How quickly this leads to impr…
Smythe Teaches Methods To Lift Operating Profits
By Robert Michel | From the Volume IV No. 8 – June 2, 1997 Issue
CEO SUMMARY: Efforts by national laboratories to improve profit margins will affect all laboratories. Consequences of this initiative will actually benefit competitors. It provides all laboratories with the opportunity to increase profits. Mark Smythe demonstrates how this can be accompli…
Roche Holdings, Ltd. Acquires Boehringer Mannheim In Merger
By Robert Michel | From the Volume IV No. 8 – June 2, 1997 Issue
CEO SUMMARY: Roche will pay $11 billion to buy Corange Ltd., parent company of Boehringer Mannheim, the world’s number two diagnostics company. Wall Street expects this deal to quicken the pace of consolidation in the healthcare industry. The surprise move will impact clinical laborator…
New Hybrid Lab Systems Provide Peek At Future
By Robert Michel | From the Volume IV No. 7 – May 12, 1997 Issue
CEO SUMMARY: As the first generation of regional laboratory systems begin operation, the marketplace is about to separate winners from losers. Stakes are high for hospital laboratory administrators. If they choose to affiliate with the wrong model, the consequences can cause extended disr…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized